RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
Go back to RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs| Gilead Sciences (NASDAQ: GILD) | Delayed: 147.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.50 | 52 Week High | $108.63 | |||
| Open | $147.50 | 52 Week Low | $71.39 | |||
| Day High | $147.50 | P/E | 81.49 | |||
| Day Low | $147.50 | EPS | $1.81 | |||
| Volume | 781 | |||||
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.48 | 52 Week High | $16.54 | |||
| Open | $0.48 | 52 Week Low | $8.10 | |||
| Day High | $0.48 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $0.00 | |||
| Volume | 10,567 | |||||
